Christian A. Kusenbach

Christian Kusenbach focuses his practice on advising corporate clients and private equity firms on national and international M&A transactions. His experience also includes general corporate, capital markets and restructuring matters.

Mr. Kusenbach’s significant representations include, among others, advising:

• Celonis, a German decacorn and global leader in execution management, currently valued at US$13 billion, in its US$400 million Series D extension led by the Qatar Investment Authority, including both new and existing investors;
• FINN, a leading car subscription platform, in its US$110 million Series B financing round led by Korelya Capital, including both new and existing investors, with an implied company value of more than US$500 million;
• Silver Lake in its strategic partnership and investment in German publicly listed company Software AG via the purchase of €344 million aggregate principal amount of subordinated unsecured convertible notes. This is the first PIPE by any U.S. technology investment firm in a German public company;
• Armira and Boxine in Boxine’s €1 billion business combination with 468 SPAC I SE, one of the first de-SPAC transactions in the market involving a German-listed blanc cheque company;
• Coty Inc. in its strategic partnership with KKR & Co. Inc. including the carveout sale of 60% of its professional beauty and retail hair businesses to KKR with an enterprise value of US$4.3 billion;
• Goldfinch Partners and The Baupost Group in their pending US$910 million carve-out acquisition of Western Union Business Solutions from The Western Union Company;
• the shareholders of Canyon Bicycles, Roman Arnold and TSG Consumer Partners in the sale of a majority stake in Canyon Bicycles to Groupe Bruxelles Lambert;
• The SCP Group in its:
• €1.2 billion acquisition of the Real Group from METRO AG; and
• sale of the digital business of Real, including the online marketplace operated under real.de, to Schwarz Gruppe;
• Medigene on its global cancer immunotherapy collaboration with BioNTech;
• phenox and its shareholders, including health care private equity investor SHS, on the sale of phenox to Wallaby Medical for a total consideration of €500 million including milestone payments;
• Dürr AG in connection with its acquisition of Hekuma GmbH from Elexis AG;
• Criteo S.A., a global technology company that provides the world’s leading Commerce Media Platform, based in Paris and listed on Nasdaq, in connection with its contemplated acquisition of shares and assets of the Iponweb group;
• the shareholders of marbis GmbH (doing business as Nitrado) in the sale and rollover of all shares to funds managed by FLEX Capital Management GmbH;
• Stemline Therapeutics in its sale to Menarini Group for up to $677 million;
• Speciality Chemicals International Limited in the sale of Polynt-Reichhold Group to funds advised by Black Diamond Group Limited;
• Hamburg Commercial Bank (f/k/a HSH Nordbank) in connection with its privatization and related matters, including the sale of a loan portfolio; and
• KAP AG in the acquisition of all shares in Oberflächentechnik Döbeln GmbH and Metallveredelung Döbeln GmbH.